What are the indications for daptomycin and apixaban in a patient after cardiac surgery?

Indications for DAPT and Apixaban Post Cardiac Surgery

The question appears to conflate two distinct clinical scenarios: "DAPT" (dual antiplatelet therapy) and "daptomycin" (an antibiotic), alongside apixaban (an anticoagulant). I will address both interpretations to ensure comprehensive guidance.

---

If the Question is About DAPTOMYCIN (Antibiotic) Post Cardiac Surgery

Daptomycin is indicated for treating serious gram-positive infections after cardiac surgery, including mediastinitis, bloodstream infections, catheter-related infections, and endocarditis caused by organisms like methicillin-resistant Staphylococcus aureus (MRSA) and vancomycin-resistant Enterococcus (VRE). 1

Specific Indications for Daptomycin:

• Complicated skin and skin structure infections (including sternal wound infections/mediastinitis)
• Staphylococcus aureus bloodstream infections (bacteremia), including right-sided infective endocarditis
• Device-related infections (VAD-associated, CIED-associated, catheter-related)
• Valve endocarditis (right-sided only; NOT indicated for left-sided endocarditis) 1

Dosing in Cardiac Surgery Patients:

• Standard dosing: 6-10 mg/kg IV every 24 hours 2
• For serious infections post-cardiac surgery: 8-10 mg/kg IV daily is preferred for bactericidal activity 2
• Duration: Typically 15.4 ± 11.8 days based on clinical response 2

Evidence Supporting Use:

A retrospective study of 65 cardiac surgical patients treated with daptomycin showed 87% success rate with minimal adverse events (only mild-to-moderate neutropenia in 2 patients) 2. Another study demonstrated daptomycin achieved adequate plasma concentrations during cardiopulmonary bypass at 8 mg/kg dosing 3. For mediastinitis specifically, 90.5% of patients showed clinical improvement within a median of 5 days 4.

Key Limitations:

• NOT indicated for pneumonia (inactivated by pulmonary surfactant) 1
• NOT indicated for left-sided endocarditis 1
• Monitor CPK levels for myopathy risk

---

If the Question is About APIXABAN (Anticoagulant) Post Cardiac Surgery

Apixaban can be safely initiated after cardiac surgery for patients requiring anticoagulation (atrial fibrillation, venous thromboembolism), but warfarin remains preferred for mechanical valve patients. 5, 6

Indications for Apixaban Post Cardiac Surgery:

1. Stroke prevention in nonvalvular atrial fibrillation (most common indication: 88.2% of cases) 7, 6
2. Treatment of DVT/PE following cardiac surgery 6
3. Bioprosthetic valve replacement (NOT mechanical valves) 5
4. Valve repair procedures 7

Timing of Initiation:

For high bleeding risk surgery (cardiac surgery): Resume apixaban 2-3 days (48-72 hours) postoperatively at full therapeutic dose 8

• Standard dose: 5 mg twice daily 8
• Reduced dose (2.5 mg twice daily): If ≥2 criteria present: age ≥80 years, weight ≤60 kg, creatinine ≥1.5 mg/dL 9
• Median postoperative day of initiation: Day 5 in clinical practice 10

Safety Profile:

A retrospective analysis of 229 cardiac surgery patients receiving DOACs (79% apixaban) showed:

• Major bleeding rate: 5.2% within 90 days 7
• Thromboembolic events: 0.4% within 90 days 7
• No difference in postoperative length of stay compared to warfarin (7 vs 9 days, p=0.59) 10

Critical Contraindications:

Apixaban is CONTRAINDICATED in patients with mechanical heart valves 5. The RE-ALIGN trial demonstrated increased strokes, MI, and valve thrombosis with DOACs versus warfarin in mechanical valve patients 5.

Renal Dosing Adjustments:

• CrCl >50 mL/min: Standard dosing
• CrCl 30-50 mL/min: Consider dose reduction based on additional criteria
• CrCl 15-30 mL/min: Use with extreme caution; limited data
• End-stage CKD on hemodialysis: 5 mg BID, reduce to 2.5 mg BID if age ≥80 or weight ≤60 kg 9

Perioperative Management Algorithm:

Preoperative discontinuation (if already on apixaban):

• Low-to-moderate bleeding risk: Stop 1 day before surgery 11
• High bleeding risk (cardiac surgery): Stop 2 days before surgery 11

Postoperative resumption:

• High bleeding risk surgery: Resume 2-3 days after surgery 8
• Consider reduced dose initially (2.5 mg BID) for high thromboembolism risk patients 8

Common Pitfalls to Avoid:

1. Do NOT use apixaban in mechanical valve patients - use warfarin exclusively 5
2. Do NOT initiate too early postoperatively - wait minimum 48 hours for adequate hemostasis 8
3. Do NOT forget to assess renal function - apixaban levels can be prolonged in CKD, potentially delaying procedures 12
4. Do NOT use bridging anticoagulation - not needed with DOACs due to rapid onset/offset 11

---

If the Question is About DUAL ANTIPLATELET THERAPY (DAPT) Post Cardiac Surgery

DAPT (aspirin + P2Y12 inhibitor) is indicated for high-risk patients after CABG, particularly those with recent acute coronary syndrome or complex coronary anatomy. 13

Timing of Initiation:

• Aspirin: Start within 6 hours postoperatively (75-100 mg daily)
• P2Y12 inhibitor: Add if high ischemic risk (recent ACS, complex disease)

Duration:

• Standard CABG: Aspirin alone indefinitely
• High-risk CABG: DAPT for 12 months, then aspirin alone 13

Preoperative Management:

• Ticagrelor: Discontinue 3 days before surgery 14
• Clopidogrel: Discontinue 5 days before surgery 14
• Prasugrel: Discontinue 7 days before surgery 14

---

Summary Algorithm

For INFECTIONS post cardiac surgery → Use DAPTOMYCIN 8-10 mg/kg IV daily

For ANTICOAGULATION post cardiac surgery:

• Mechanical valves → WARFARIN only
• Bioprosthetic valves/AF/VTE → APIXABAN 5 mg BID starting 48-72 hours postop
• Adjust dose for age ≥80, weight ≤60 kg, or CrCl <50 mL/min